Inventor
LV BINHUA
CN21 patents
⚠️ This page may combine multiple inventors who share the name “LV BINHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD
7 patentsUS9809572B2Nov 7, 2017
Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD5 citations77
US11459327B1Oct 4, 2022
Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD6 citations69
US9604935B2Mar 28, 2017
Deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the same
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD3 citations68
US10544185B2Jan 28, 2020
Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD1 citations59
US10377725B2Aug 13, 2019
Phenyl amino pyrimidine compound or polymorph of salt thereof
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD1 citations59
US10414767B2Sep 17, 2019
Deuterated quinazolinone compound and pharmaceutical composition comprising same
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD0 citations49
US10618884B2Apr 14, 2020
Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD0 citations45
THERACOS INC
5 patentsUS7838499B2Nov 23, 2010
Benzylbenzene derivatives and methods of use
THERACOS INC35 citations91
US8802637B2Aug 12, 2014
Benzylbenzene derivatives and methods of use
THERACOS INC7 citations82
US7838498B2Nov 23, 2010
Benzylic glycoside derivatives and methods of use
THERACOS INC19 citations82
US9193751B2Nov 24, 2015
Process for the preparation of benzylbenzene SGLT2 inhibitors
THERACOS INC4 citations72
US7803778B2Sep 28, 2010
Glucose transport inhibitors and methods of use
THERACOS INC0 citations41
THERACOS SUB LLC
4 patentsUS10533032B2Jan 14, 2020
Crystalline form of benzylbenzene SGLT2 inhibitor
THERACOS SUB LLC4 citations82
US9834573B2Dec 5, 2017
Crystalline form of benzylbenzene SGLT2 inhibitor
THERACOS SUB LLC4 citations82
US10981942B2Apr 20, 2021
Crystalline form of benzylbenzene SGLT2 inhibitor
THERACOS SUB LLC3 citations71
US9725478B2Aug 8, 2017
Process for the preparation of benzylbenzene SGLT2 inhibitors
THERACOS SUB LLC2 citations71